Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Mineralys Therapeutics, Inc. Common Stock

MLYS
Current price
12.17 USD -0.28 USD (-2.25%)
Last closed 12.45 USD
Company
ISIN US6031701013
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 698 162 880 USD
Yield for 12 month +79.50 %
1Y
3Y
5Y
10Y
15Y
MLYS
21.11.2021 - 28.11.2021

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and chronic kidney diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone. The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania. Address: 150 N. Radnor Chester Rd., Radnor, PA, United States, 19087

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

32.5 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

-9 000 USD

Last Quarter

-8 000 USD

Key Figures MLYS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA
Operating Margin TTM
PE Ratio
Return On Assets TTM -27.58 %
PEG Ratio
Return On Equity TTM -41.62 %
Wall Street Target Price 32.5 USD
Revenue TTM
Book Value 5.84 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -2.76 USD
Diluted Eps TTM -2.76 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics MLYS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History MLYS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation MLYS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -7.4117
Price Book MRQ 2.4067

Financials MLYS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MLYS

For 52 weeks

5.85 USD 16.91 USD
50 Day MA 12.9 USD
Shares Short Prior Month 1 586 044
200 Day MA 12.82 USD
Short Ratio 11.47
Shares Short 1 613 175
Short Percent 4.75 %